Succinate dehydrogenase: Prospect for neurodegenerative diseases

Akundi, 2011, Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice, PLoS One, 6, e16038, 10.1371/journal.pone.0016038 Asiimwe, 2016, Nitric oxide: exploring the contextual link with Alzheimer's disease, Oxidative Med. Cell. Longev., 2016, 7205747, 10.1155/2016/7205747 Beal, 1993, Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate, J. Neurochem., 61, 1147, 10.1111/j.1471-4159.1993.tb03633.x Benecke, 1993, Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes, Brain, 116, 1451, 10.1093/brain/116.6.1451 Bolaños, 1995, Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary cultures, J. Neurochem., 64, 1965, 10.1046/j.1471-4159.1995.64051965.x Bonny, 2005, Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases, Rev. Neurosci., 16, 57, 10.1515/REVNEURO.2005.16.1.57 Borsello, 2007, JNK signalling: a possible target to prevent neurodegeneration, Curr. Pharm. Des., 13, 1875, 10.2174/138161207780858384 Brenner, 2006, The permeability transition pore complex in cancer cell death, Oncogene, 25, 4744, 10.1038/sj.onc.1209609 Brookes, 1998, Peroxynitrite and brain mitochondria: evidence for increased proton leak, J. Neurochem., 70, 2195, 10.1046/j.1471-4159.1998.70052195.x Brustovetsky, 2003, Two pathways for tBID-induced cytochrome c release from rat brain mitochondria: BAK- versus BAX-dependence, J. Neurochem., 84, 196, 10.1046/j.1471-4159.2003.01545.x Camargo, 2009, SREBPs: SREBP function in glia-neuron interactions, FEBS J., 276, 628, 10.1111/j.1742-4658.2008.06808.x Casley, 2002, Beta-amyloid fragment 25–35 causes mitochondrial dysfunction in primary cortical neurons, Neurobiol. Dis., 10, 258, 10.1006/nbdi.2002.0516 Cecchini, 2003, Function and structure of complex II of the respiratory chain, Annu. Rev. Biochem., 72, 77, 10.1146/annurev.biochem.72.121801.161700 Chavez, 1997, Membrane permeability transition as induced by dysfunction of the electron transport chain, Biochem. Mol. Biol. Int., 41, 961 Choo, 2004, Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release, Hum. Mol. Genet., 13, 1407, 10.1093/hmg/ddh162 Cincioglu, 2012, Indinavir inhibits the expression of cytoplasmic aromatase and nuclear SREBP in the hippocampus of reperfusion injury-induced ischemic rats, J. Steroid Biochem. Mol. Biol., 130, 81, 10.1016/j.jsbmb.2012.01.011 Coyle, 1976, Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea, Nature, 263, 244, 10.1038/263244a0 Dagda, 2009, Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models, Mitochondrion, 9, 289, 10.1016/j.mito.2009.06.001 Damiano, 2013, A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin, Hum. Mol. Genet., 22, 3869, 10.1093/hmg/ddt242 Davis, 2012, Mitochondrial function and dysfunction: an update, J. Pharmacol. Exp. Ther., 342, 598, 10.1124/jpet.112.192104 Dawson, 1996, Nitric oxide neurotoxicity, J. Chem. Neuroanat., 29, 97 Demuro, 2005, Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers, J. Biol. Chem., 280, 17294, 10.1074/jbc.M500997200 Deng, 2014, β-amyloid impairs the regulation of N-methyl-d-aspartate receptors by glycogen synthase kinase 3, Neurobiol. Aging, 35, 449, 10.1016/j.neurobiolaging.2013.08.031 Devi, 2010, Mitochondrial trafficking of APP and alpha synuclein: relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases, Biochim. Biophys. Acta, 1802, 11, 10.1016/j.bbadis.2009.07.007 Dröse, 2011, A common mechanism links differently acting complex II inhibitors to cardioprotection: modulation of mitochondrial reactive oxygen species production, Mol. Pharmacol., 79, 814, 10.1124/mol.110.070342 Düvel, 2010, Activation of a metabolic gene regulatory network downstream of mTOR complex 1, Mol. Cell, 39, 171, 10.1016/j.molcel.2010.06.022 Eberlé, 2004, SREBP transcription factors: master regulators of lipid homeostasis, Biochimie, 86, 839, 10.1016/j.biochi.2004.09.018 Eichner, 2011, Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks, Mitochondrion, 11, 544, 10.1016/j.mito.2011.03.121 Fernandez-Gomez, 2005, Malonate induces cell death via mitochondrial potential collapse and delayed swelling through an ROS-dependent pathway, Br. J. Pharmacol., 144, 528, 10.1038/sj.bjp.0706069 Fukai, 2011, Superoxide dismutases: role in redox signaling, vascular function, and diseases, Antioxid. Redox Signal., 15, 1583, 10.1089/ars.2011.3999 Furukawa, 2006, Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells, J. Neurochem., 97, 1071, 10.1111/j.1471-4159.2006.03803.x Giorgi, 2012, Mitochondrial calcium homeostasis as potential target for mitochondrial medicine, Mitochondrion, 12, 77, 10.1016/j.mito.2011.07.004 Greenberg, 2011, The role of lipid droplets in metabolic disease in rodents and humans, J. Clin. Invest., 121, 2102, 10.1172/JCI46069 Grimm, 2013, Respiratory chain complex II as general sensor for apoptosis, Biochim. Biophys. Acta, 1827, 565, 10.1016/j.bbabio.2012.09.009 Gu, 1996, Mitochondrial defect in Huntington's disease caudate nucleus, Ann. Neurol., 39, 385, 10.1002/ana.410390317 Guo, 2003, The ubiquinone-binding site of the Saccharomyces cerevisiae succinate-ubiquinone oxidoreductase is a source of superoxide, J. Biol. Chem., 278, 47629, 10.1074/jbc.M306312200 Guo, 2016, Inhibition of mitochondrial complex II by the anticancer agent lonidamine, J. Biol. Chem., 291, 42, 10.1074/jbc.M115.697516 Gupta, 1996, Selective interaction of JNK protein kinase isoforms with transcription factors, EMBO J., 15, 2760, 10.1002/j.1460-2075.1996.tb00636.x Gutman, 1971, Control of succinate dehydrogenase in mitochondria, Biochemistry, 10, 4763, 10.1021/bi00801a025 Haas, 1995, Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease, Ann. Neurol., 37, 714, 10.1002/ana.410370604 Hägerhäll, 1997, Succinate: quinone oxidoreductases. Variations on a conserved theme, Biochim. Biophys. Acta, 1320, 107, 10.1016/S0005-2728(97)00019-4 Hara, 2007, Cell signaling and neuronal death, Annu. Rev. Pharmacol. Toxicol., 47, 117, 10.1146/annurev.pharmtox.47.120505.105311 Hattori, 1991, Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease, Ann. Neurol., 30, 563, 10.1002/ana.410300409 Horton, 2002, SREBPs: transcriptional mediators of lipid homeostasis, Cold Spring Harb. Symp. Quant. Biol., 67, 491, 10.1101/sqb.2002.67.491 Hu, 2015, The MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells, Int. J. Mol. Med., 36, 130, 10.3892/ijmm.2015.2195 Huang, 2014, Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases, Neurobiol. Dis., 72, 3, 10.1016/j.nbd.2014.08.025 Jamwal, 2017, l-theanine, a component of green tea prevents 3-Nitropropionic acid (3-NP)-induced striatal toxicity by modulating nitric oxide pathway, Mol. Neurobiol., 54, 2327, 10.1007/s12035-016-9822-5 Jiménez-Jiménez, 2016, An update on the role of nitric oxide in the neurodegenerative processes of Parkinson's disease, Curr. Med. Chem., 23, 2666, 10.2174/0929867323666160812151356 Jodeiri Farshbaf, 2016, Nurr1 and PPARγ protect PC12 cells against MPP+ toxicity: involvement of selective genes, anti-inflammatory, ROS generation, and antimitochondrial impairment, Mol. Cell. Biochem., 420, 29, 10.1007/s11010-016-2764-4 Jodeiri Farshbaf, 2016, Does PGC1α/FNDC5/BDNF elicit the beneficial effects of exercise on neurodegenerative disorders?, NeuroMolecular Med., 18, 1, 10.1007/s12017-015-8370-x Khatchadourian, 2012, Dynamics and regulation of lipid droplet formation in lipopolysaccharide (LPS)-stimulated microglia, Biochim. Biophys. Acta, 1821, 607, 10.1016/j.bbalip.2012.01.007 Kim, 2015, Excess lipid accumulation in cortical neurons in multiple sclerosis may lead to autophagic dysfunction and neurodegeneration, Neurology, 84, P5.237 Knowles, 1994, Nitric oxide synthases in mammals, Biochem. J., 298, 249, 10.1042/bj2980249 Kraytsberg, 2006, Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons, Nat. Genet., 38, 518, 10.1038/ng1778 Langston, 1983, Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, N. Engl. J. Med., 309, 310, 10.1056/NEJM198308043090511 Legros, 2004, Organization and dynamics of human mitochondrial DNA, J. Cell Sci., 117, 2653, 10.1242/jcs.01134 Lin, 2006, Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases, Nature, 443, 787, 10.1038/nature05292 Liu, 2015, Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration, Cell, 160, 177, 10.1016/j.cell.2014.12.019 Long, 2012, New evidence of mitochondria dysfunction in the female Alzheimer's disease brain: deficiency of estrogen receptor-β, J. Alzheimers Dis., 30, 545, 10.3233/JAD-2012-120283 Loschen, 1974, Superoxide radicals as precursors of mitochondrial hydrogen peroxide, FEBS Lett., 42, 68, 10.1016/0014-5793(74)80281-4 Maiese, 2016, Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders, Br. J. Clin. Pharmacol., 82, 1245, 10.1111/bcp.12804 Mailloux, 2015, Teaching the fundamentals of electron transfer reactions in mitochondria and the production and detection of reactive oxygen species, Redox Biol., 4, 381, 10.1016/j.redox.2015.02.001 Manczak, 2004, Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage, NeuroMolecular Med., 5, 147, 10.1385/NMM:5:2:147 Martin, 2010, Mitochondrial and cell death mechanisms in neurodegenerative diseases, Pharmaceuticals (Basel), 3, 839, 10.3390/ph3040839 Martin, 2006, Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death, J. Neurosci., 26, 41, 10.1523/JNEUROSCI.4308-05.2006 Moncada, 2006, Nitric oxide, cell bioenergetics and neurodegeneration, J. Neurochem., 97, 1676, 10.1111/j.1471-4159.2006.03988.x Nicholls, 2002, Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease, Int. J. Biochem. Cell Biol., 34, 1372, 10.1016/S1357-2725(02)00077-8 Niemann, 2000, Mutations in SDHC cause autosomal dominant paraganglioma, type 3, Nat. Genet., 26, 268, 10.1038/81551 Nulton-Persson, 2001, Modulation of mitochondrial function by hydrogen peroxide, J. Biol. Chem., 276, 23357, 10.1074/jbc.M100320200 Okamoto, 2006, Sterol regulatory element binding protein (SREBP)-1 expression in brain is affected by age but not by hormones or metabolic changes, Brain Res., 1081, 19, 10.1016/j.brainres.2006.01.081 Owen, 2002, The key role of anaplerosis and cataplerosis for citric acid cycle function, J. Biol. Chem., 277, 30409, 10.1074/jbc.R200006200 Parfait, 2000, Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome, Hum. Genet., 106, 236, 10.1007/s004390051033 Petlicki, 1998, The equilibrium between the oxidation of hydrogen peroxide by oxygen and the dismutation of peroxyl or superoxide radicals in aqeous solutions in contact with oxygen, J. Chem. Soc. Faraday Trans., 94, 2763, 10.1039/a804551h Poderos, 1998, Nitric oxide regulates oxygen uptake and hydrogen peroxide release by the isolated beating rat heart, Am. J. Phys., 274, C112, 10.1152/ajpcell.1998.274.1.C112 Porstmann, 2008, SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth, Cell Metab., 8, 224, 10.1016/j.cmet.2008.07.007 Radi, 1991, Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide, J. Biol. Chem., 266, 4244, 10.1016/S0021-9258(20)64313-7 Ralph, 2011, Inhibitors of succinate: quinone reductase/Complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death, Pharm. Res., 28, 2695, 10.1007/s11095-011-0566-7 Rizzuto, 2000, Mitochondria as all-round players of the calcium game, J. Physiol., 529, 37, 10.1111/j.1469-7793.2000.00037.x Rottenberg, 1977, Control of the rate of reverse electron transport in submitochondrial particles by the free energy, Biochemistry, 16, 3220, 10.1021/bi00633a028 Sakakura, 2001, Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis, Biochem. Biophys. Res. Commun., 286, 176, 10.1006/bbrc.2001.5375 Schwall, 2012, The stability and activity of respiratory complex II is cardiolipin-dependent, Biochim. Biophys. Acta, 1817, 1588, 10.1016/j.bbabio.2012.04.015 Scimemi, 2013, Amyloid-β1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1, J. Neurosci., 33, 5312, 10.1523/JNEUROSCI.5274-12.2013 Selak, 2005, Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase, Cancer Cell, 7, 77, 10.1016/j.ccr.2004.11.022 Shehadeh, 2006, Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease, Neurobiol. Dis., 21, 392, 10.1016/j.nbd.2005.08.001 Shimabukuro, 2016, Lipid-laden cells differentially distributed in the aging brain are functionally active and correspond to distinct phenotypes, Sci. Rep., 6, 23795, 10.1038/srep23795 Silva, 2013, Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers, Mitochondrion, 13, 801, 10.1016/j.mito.2013.05.006 Soussi, 1990, Cytochrome c oxidase and cardiolipin alterations in response to skeletal muscle ischaemia and reperfusion, Acta Physiol. Scand., 138, 107, 10.1111/j.1748-1716.1990.tb08822.x Sparagna, 1995, Mitochondrial calcium uptake from physiological-type pulses of calcium. A description of the rapid uptake mode, J. Biol. Chem., 270, 27510, 10.1074/jbc.270.46.27510 Stout, 1998, Glutamate-induced neuron death requires mitochondrial calcium uptake, Nat. Neurosci., 1, 366, 10.1038/1577 Sun, 2005, Crystal structure of mitochondrial respiratory membrane protein complex II, Cell, 121, 1043, 10.1016/j.cell.2005.05.025 Tabrizi, 2000, Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse, Ann. Neurol., 47, 80, 10.1002/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K Taghibiglou, 2009, Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries, Nat. Med., 15, 1399, 10.1038/nm.2064 Taylor, 2013, MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition, J. Neurosci., 33, 2313, 10.1523/JNEUROSCI.4965-11.2013 Túnez, 2010, 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington disease: past, present, and future, Molecules, 15, 878, 10.3390/molecules15020878 Van Vranken, 2014, SDHAF4 promotes mitochondrial succinate dehydrogenase activity and prevents neurodegeneration, Cell Metab., 20, 241, 10.1016/j.cmet.2014.05.012 Villa-Cuesta, 2014, Rapamycin increases mitochondrial efficiency by mtDNA-dependent reprogramming of mitochondrial metabolism in Drosophila, J. Cell Sci., 127, 2282, 10.1242/jcs.142026 Walter, 2013, Cross-talk of membrane lipids and Alzheimer-related proteins, Mol. Neurodegener., 22, 34, 10.1186/1750-1326-8-34 Weisiter, 1973, Superoxide dismutase. Organelle specificity, J. Biol. Chem., 248, 3582, 10.1016/S0021-9258(19)43969-0 Yan, 2013, Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease, Free Radic. Biol. Med., 62, 90, 10.1016/j.freeradbiomed.2012.11.014 Younce, 2012, MCP-1 induced protein promotes adipogenesis via oxidative stress, endoplasmic reticulum stress and autophagy, Cell. Physiol. Biochem., 30, 307, 10.1159/000339066 Zhang, 2007, HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity, Cancer Cell, 11, 407, 10.1016/j.ccr.2007.04.001 Zhang, 2016, Recent advance in the relationship between excitatory amino acid transporters and Parkinson's disease, Neural Plast., 2016, 8941327, 10.1155/2016/8941327 Zhou, 2015, Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice, Ann. Neurol., 77, 637, 10.1002/ana.24361 Zipfel, 2000, Neuronal apoptosis after CNS injury: the roles of glutamate and calcium, J. Neurotrauma, 17, 857, 10.1089/neu.2000.17.857